"Cell Proliferation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
All of the processes involved in increasing CELL NUMBER including CELL DIVISION.
| Descriptor ID |
D049109
|
| MeSH Number(s) |
G04.161.750 G07.345.249.410.750
|
| Concept/Terms |
Cell Proliferation- Cell Proliferation
- Proliferation, Cell
- Cellular Proliferation
- Proliferation, Cellular
- Cell Multiplication
- Multiplication, Cell
- Cell Growth in Number
- Cell Number Growth
- Growth, Cell Number
- Number Growth, Cell
|
Below are MeSH descriptors whose meaning is more general than "Cell Proliferation".
Below are MeSH descriptors whose meaning is more specific than "Cell Proliferation".
This graph shows the total number of publications written about "Cell Proliferation" by people in this website by year, and whether "Cell Proliferation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2004 | 2 | 17 | 19 |
| 2005 | 6 | 38 | 44 |
| 2006 | 7 | 48 | 55 |
| 2007 | 5 | 46 | 51 |
| 2008 | 13 | 59 | 72 |
| 2009 | 11 | 58 | 69 |
| 2010 | 12 | 59 | 71 |
| 2011 | 7 | 80 | 87 |
| 2012 | 8 | 63 | 71 |
| 2013 | 15 | 88 | 103 |
| 2014 | 13 | 90 | 103 |
| 2015 | 12 | 90 | 102 |
| 2016 | 15 | 94 | 109 |
| 2017 | 13 | 94 | 107 |
| 2018 | 15 | 85 | 100 |
| 2019 | 15 | 66 | 81 |
| 2020 | 9 | 75 | 84 |
| 2021 | 6 | 59 | 65 |
| 2022 | 0 | 21 | 21 |
| 2023 | 0 | 27 | 27 |
| 2024 | 5 | 38 | 43 |
| 2025 | 3 | 43 | 46 |
| 2026 | 2 | 31 | 33 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Proliferation" by people in Profiles.
-
Nervous system integrity in Drosophila: essential and dosage-sensitive roles of Hsp110. Genetics. 2026 Nov 04; 234(3).
-
Citron kinase activity controls alternative splicing events that drive prostate cancer growth. Sci Adv. 2026 Oct 09; 12(41):eaee5257.
-
Nuclear export as a therapeutic vulnerability in ZFTA-RELA ependymoma. Neuro Oncol. 2026 Oct 01; 28(10):2472-2484.
-
Selective histone deacetylase inhibition as a therapeutically relevant strategy in H3K27M-glioma. Neuro Oncol. 2026 Oct 01; 28(10):2485-2499.
-
A TBK1/ULK1 signalling axis couples lysosomal stress to TFEB activation. Nature. 2026 Nov; 659(8139):238-247.
-
A metabolic-epigenetic switch governs multicellular cardiac repair following succinate dehydrogenase inhibition. Nat Cardiovasc Res. 2026 Oct; 5(10):1034-1054.
-
p63 and p73 drive cutaneous squamous cell carcinoma through convergent transcriptional control of EGFR signaling. Cell Rep. 2026 Oct 27; 45(10):118030.
-
CAMKV kinase drives neuroblastoma growth and acts as a novel therapeutic target. J Exp Med. 2026 Oct 05; 223(10).
-
Dynamic fluid flow and endothelial cross talk regulate mesangial homeostasis in a simplified 3-D coculture model. Am J Physiol Renal Physiol. 2026 09 01; 331(3):F513-F528.
-
Interfacial lipid digestion-responsive injectable nanoemulsions enhance lapatinib efficacy in triple-negative breast cancer. Colloids Surf B Biointerfaces. 2026 Dec; 268(Pt 2):116079.